妊娠期急性白血病与侵袭性淋巴瘤诊断和管理立场声明
妊娠期血液系统恶性肿瘤发病率为每10万次妊娠12.5例,近二十年来显著增加。该立场声明由澳大利亚-新西兰多学科工作组基于现有证据与专家共识制定,提供妊娠期诊断分期、影像安全、治疗、支持治疗、生育力保护及妊娠分娩管理推荐,并获得三家学会理事会审核认可。
要点
- 妊娠期急性白血病和侵袭性淋巴瘤需多学科团队管理,兼顾母胎安全与治愈性治疗。
- 声明涵盖妊娠期影像安全检查、诊断分期及治疗推荐,基于证据与专家共识。
- 目前尚无妊娠期血液肿瘤临床实践指南,本声明为首次多学科立场声明。
核心结论
- 妊娠期急性白血病和侵袭性淋巴瘤需多学科协作,在追求患者最佳治愈性治疗的同时保障成功妊娠结局。
研究设计与样本
- 澳大利亚-新西兰工作组制定的立场声明,成员来自血液科、产科医学、临床畸胎学、放射科、核医学科、母胎医学及患者代表,基于现有证据与专家共识。
- 声明经澳大利亚和新西兰产科医学学会、澳大利亚和新西兰血液学会及产科与女性健康血液学协作组理事会审核认可。
临床应用与阅片要点
- 声明提供妊娠期诊断与分期、妊娠期影像安全检查、妊娠期治疗(含多学科方法)、支持治疗、生育力保护及妊娠与分娩管理的推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Haematological malignancies affect 12·5 in 100 000 pregnancies. Over the past two decades, the number of haematological malignancies in pregnancy has substantially increased. Life-threatening haematological malignancies in pregnancy, such as acute leukaemia and aggressive lymphomas, pose a unique therapeutic challenge: clinicians must consider both maternal and fetal wellbeing, aiming to deliver optimal curative therapy for the patient and a successful pregnancy outcome. A multidisciplinary approach to disease management is paramount, and there are currently no clinical practice guidelines available. An Australasian working group, including representatives from haematology, obstetric medicine, clinical teratology, radiology, nuclear medicine, maternal-fetal medicine, and a patient representative, was established to develop this position statement, which is based on a combination of current evidence and expert consensus. We provide recommendations for diagnosis and staging, imaging safety in pregnancy, therapy in pregnancy incorporating a multidisciplinary approach, supportive care, oncofertility, and pregnancy and birth management. This Viewpoint was reviewed and endorsed by the councils of the Society of Obstetric Medicine of Australia and New Zealand, the Haematology Society of Australia and New Zealand, and the Haematology in Obstetric and Women's Health Collaborative.
引用
- Mills G, Shand A, Kennedy D, et al. Position statement on the diagnosis and management of acute leukaemia and aggressive lymphomas in pregnancy. Lancet Haematol. 2025. PMID: 39761682. doi:10.1016/S2352-3026(24)00309-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。